Find Academic Supervisors

Nikolaos LaskarisView profile

Assistant Professor

• Archaeometry
• Cultural Heritage Science
• Non-Destructive Testing
• +5 more

Nikolaos Laskaris serves as Assistant Professor at the University of West Attica's Department of Industrial Design and Production Engineering, specializing in Electronics with Applications in Art and Environment through Non-Destructive Testing and Systems Diagnosis Methodologies. His academic foundation includes: Bachelor's in Electronics (Industrial Electronics specialization) from Technological Educational Institute of Lamia Doctoral/postdoctoral research in non-destructive analysis techniques for cultural heritage and environmental applications Dr. Laskaris pioneers Archaeometry and Cultural Heritage Science , revolutionizing obsidian hydration dating to redefine Aegean navigation timelines. His research integrates Electronics and Materials Science for pigment identification in Byzantine icons, 3D heritage digitization, and micro/nano-electronics fabrication. Recent expansion into Robotics for environmental monitoring and Health Technology for aphasia rehabilitation demonstrates exceptional interdisciplinary range. Publication trends reveal strategic diversification: while maintaining core expertise in cultural heritage diagnostics (evident in 2024 sarcophagus and sigillia studies), he now leads cutting-edge work in unmanned vehicle systems (2025 defense/environmental applications), human-robot interfaces (2025 speech recognition), and neurorehabilitation technologies (2024 aphasia studies). His research portfolio includes: Characterization of CdTe/CdZnTe defect structures Non-destructive analysis of Thessalian ecclesiastical metalwork Development of modified XRF/Raman techniques Sediment pollution studies in Gulf of Elefsina He serves as NSF USA reviewer (2019-2020) and journals reviewer for Elsevier/Springer/MDPI. Dr. Laskaris directs the Non-Destructive Testing and Systems Diagnosis Methodologies laboratory, driving innovation in heritage preservation through advanced electronics and robotics integration.

• Neuropsychology
• Neurorehabilitation
• Telerehabilitation
• +7 more

Lucia Willadino Braga, PhD, is Professor in the Department of Psychiatry and Behavioral Sciences at both UMass Chan Medical School and T.H. Chan School of Medicine . She is additionally affiliated with the SARAH Network of Rehabilitation Hospitals in Brasília, Brazil, where her clinical and research activities focus on neuropsychology and neurorehabilitation across the lifespan. Education & Training BS, Psychology & Music – University of Brasília, Brazil MS, Education – University of Brasília, Brazil PhD, Neuropsychology – University of Brasília, Brazil Research Focus Dr. Braga’s scholarship centers on understanding and improving neuropsychological outcomes for individuals with acquired brain injuries and neurodevelopmental conditions. Her work integrates telerehabilitation technologies with evidence-based cognitive rehabilitation, examines the genetic underpinnings of cerebral palsy , and explores neuroplastic responses to therapeutic interventions in both pediatric and adult populations. Across more than two decades of research, she has conducted pioneering randomized controlled trials comparing family-supported versus clinician-delivered rehabilitation, developed normative tools for fine-motor assessment in children with cerebral palsy, and investigated structural brain correlates of cognitive outcomes after severe traumatic brain injury. Publication Trends Her publication record spans from 2004 to 2024, with notable acceleration in recent years addressing Long COVID cognitive sequelae and the sustained impact of telerehabilitation services . Studies are concentrated in journals classified under neurology, pediatrics, neurorehabilitation, and physical medicine, reflecting an interdisciplinary approach to translating neuroscience findings into rehabilitative practice. Grants, Awards & Recognition While specific awards are not enumerated in the provided texts, Dr. Braga’s research has garnered substantial citations (e.g., 27 citations for her 2005 Brain Injury paper) and has been referenced in policy sources and social-media discussions, underscoring translational impact. Clinical & Research Environment Operating within the SARAH Network—a leading South American rehabilitation system—Dr. Braga leverages its multidisciplinary teams and state-of-the-art facilities to conduct longitudinal neuropsychological studies and clinical trials. Her dual appointments in the United States and Brazil facilitate international collaboration in neurorehabilitation research and education.

• First Language Acquisition
• Typical and Atypical Language Development
• Genetic Disorders
• +8 more

Christiana Christodoulou is a Research Assistant Professor of Linguistics in the Department of Modern Languages at the University of Mississippi , with a focus on experimental and theoretical linguistics. She teaches courses such as Language and Mind , Psycholinguistics , and Syntax . B.A. in Linguistics, Aristotle University of Thessaloniki (1999) M.A. in Linguistics, University of Essex (2001) DB.A. in English Language and Literature, Aristotle University of Thessaloniki (2011) Ph.D. in Linguistics, University of British Columbia (2011) Her experimental research explores First Language Acquisition , Typical and Atypical Language Development , Genetic Disorders , and Neurolinguistics , particularly in Down Syndrome populations. The theoretical research focuses on Morphology , Syntax , and Functional Categories (e.g., case, tense, aspect) as well as Subjunctives and Interface Effects across linguistic domains. Christodoulou’s publications span topics from morphosyntactic development in Down Syndrome children to subjunctive clauses, coreference in Greek, and phonetic analysis of Cypriot Greek. Her work frequently intersects with Developmental Psychology , Neurolinguistics , and Formal Grammar . Marie Skłodowska-Curie Global Grant (2017–2021) Marie Curie Career Integration Grant (2012–2015) Canadian Commonwealth Scholarship Program (2005-2010) AHEPA Award for Outstanding Academic Achievement and Community Service (2009) Fieldwork and Research Award (2008) Her interdisciplinary work involves collaborations in Clinical Linguistics , Genetic Disorders , and Language Documentation , particularly in endangered Indigenous languages like Wenatchi.

Elena TenenbaumView profile

Assistant Professor

• Language Acquisition
• Cognitive Development
• Autism Spectrum Disorder
• +7 more

Elena Tenenbaum is an Assistant Professor in Psychiatry and Behavioral Sciences and Psychology and Neuroscience at Duke University, where she is also a Faculty Network Member of the Duke Institute for Brain Sciences . Her research focuses on language acquisition and cognitive development in children with autism spectrum disorder (ASD) , particularly those who are minimally verbal. She employs eye-tracking , EEG , and remote assessment tools to investigate social attention, audio-visual processing, and executive function in ASD. Education: Ph.D. in Psychology from Brown University (2011), Clinical Psychology respecialization at Suffolk University. Her work bridges neuroscience and clinical psychology to understand ASD heterogeneity, with a focus on early intervention and perinatal influences . Recent publications highlight scalable remote methodologies like the RISE Battery for infant cognitive studies and LVIS for assessing communicative competence in low-verbal ASD. She has received grants including the Meeting on Language in Autism (2025-2028) and Shenoy Undergraduate Research Fellowship in Neuroscience (2025-2026). Awards include fellowships and research grants for ASD and developmental disorders. Her lab collaborates on digital phenotyping , audio-visual synchrony , and social attention mechanisms .

Gaia LapomardaView profile

Researcher

• Affective Neuroscience
• Emotion Regulation
• Clinical Psychology
• +3 more

Dr. Gaia Lapomarda is a researcher at the Institute of Psychology, University of Innsbruck, based in the Department of Affective Neuroscience. Her work integrates neuroscience and psychology to explore how emotional states influence cognition and perception, with a strong focus on clinical applications. Research Interests: Affective neuroscience and emotion regulation mechanisms EEG-based biomarkers of emotional processing Neuroimaging of psychiatric disorders (bipolar disorder, borderline personality disorder) Impact of childhood trauma on brain structure and function Temporal perception and sensory processing under emotional states Her research bridges basic neuroscience with clinical psychiatry, employing advanced techniques like multimodal neuroimaging (mCCA+jICA), machine learning for biomarker discovery, and EEG-based investigations of neural oscillations. A recurring theme is how affective states modulate fundamental cognitive processes like time perception and visual processing speed. Key Findings from Publications: Dr. Lapomarda's work reveals altered thalamic-parahippocampal circuits in schizophrenia/bipolar disorder, demonstrates sustained EEG changes post-emotion regulation, and identifies structural brain patterns predicting trauma-related symptoms in borderline personality disorder. Her 2025 study on language comprehension adds a novel social dimension, exploring how perceived speaker identity influences sentence processing.

Sridhar KrishnamurtiView profile

Professor

• Electrophysiology
• Hearing Aids
• Hearing Conservation
• +3 more

Sridhar Krishnamurti serves as Professor and Audiology Graduate Program Officer in Auburn University's Department of Speech, Language and Hearing Sciences within the College of Liberal Arts. His Haley Center office (1102) supports his dual roles as AuD program coordinator and director of the Auditory and Hearing Science Lab. His educational foundation includes a PhD from Kent State University, Master's and Bachelor's degrees from India's All India Institute of Speech and Hearing, and clinical fellowship training at Harvard Medical School's Massachusetts Eye and Ear Infirmary. Research spans electrophysiology, hearing conservation, and auditory processing disorders with emphasis on aging populations. Current investigations focus on neural network modeling of auditory-cognitive decline, hearing aid efficacy in dementia, and military/musician hearing conservation. His lab employs otoacoustic emissions, VEMP, and pupillometry to assess auditory plasticity and stress. Recent publications reveal increasing integration of computational methods with clinical audiology, particularly neural network applications for diagnosing auditory processing disorders and modeling Alzheimer's-related hearing decline. Military and music-related hearing conservation remains a consistent thread across his work. Scientific recognition includes: 1999 New Investigator Research Award (American Academy of Audiology) 2011 Auburn University Teaching Excellence Award 2012 Auburn University Faculty Research Award Fellowship in the American Academy of Audiology He actively mentors students in research projects while serving on Alzheimer's Association grant panels and journal review boards. Current grant activities focus on warfighter hearing protection and musician hearing conservation. The Auditory and Hearing Science Lab conducts experimental research on auditory localization, situational awareness devices, and noise-induced hearing loss mechanisms through collaborations with military and music programs.

Douglas M. ShillerView profile

Professor

• Speech Production
• Speech Perception
• Phonetic Development
• +3 more

Douglas M. Shiller is a Full Professor at the University of Montreal specializing in speech production, perception, and motor control mechanisms. His research bridges experimental psychology and clinical speech-language pathology, with a focus on neural and cognitive processes underlying speech. He holds a PhD in Experimental Psychology and a Master's degree in Speech-Language Pathology, both from McGill University. His educational background provides a strong foundation for investigating both theoretical and clinical aspects of speech. Shiller's primary research interests include speech production and perception dynamics, phonetic development across the lifespan, and sensorimotor learning in speech. He examines how auditory and somatosensory feedback contribute to speech adaptation, the impact of neurological conditions on speech, and cross-language transfer mechanisms in bilingual speakers. Analysis of his 15 most recent publications (2018-2023) reveals dominant trends in sensorimotor integration during speech, with significant emphasis on perturbation-based adaptation studies, stuttering mechanisms, Parkinson's disease effects, and bilingual speech processing. His work frequently employs real-time biofeedback techniques and examines individual differences in speech motor learning across populations. Shiller maintains active affiliations with multiple research centers including the Research Centre of CHU Sainte-Justine, the Research Centre on Brain, Language and Music (CRBLM), the International Laboratory for Brain, Music and Sound Research (BRAMS), and the Engineering of Interactive Technologies in Rehabilitation (INTER). These collaborations enable interdisciplinary approaches to speech science and clinical applications.

• Speech Neuroscience
• Neuroimaging
• Neuroanatomy

Jason Tourville is a Researcher at Boston University, focusing on speech motor control. He is affiliated with the Graduate Program for Neuroscience and the Center for Computational Neuroscience and Neural Technologies. His work integrates neuroimaging, computational modeling, and clinical research in speech disorders. B.A., Neuroscience, Oberlin College (1996) Ph.D., Cognitive and Neural Systems, Boston University (2008) Tourville’s research spans speech neuroscience, neuroimaging, and neuroanatomy, with emphasis on stuttering, autism spectrum disorder, and speech motor sequence learning. He utilizes fMRI, MRI, and computational models to investigate cortical mechanisms in speech production and disorders. His recent work explores functional connectivity subtypes in stuttering, neurodegenerative disease manifestations, and structural morphometry differences in speech-related brain regions. Awards include the Boston University Graduate Research Fellowship and Outstanding Teaching Fellow recognition. NIH R01 DC007683 (Investigator, 2011-2016) NIH R01 DC002852 (Investigator, 2011-2016) NIH R01 MH084029 (Consultant, 2009-2012)

Henry BrodatyView profile

Professor

• Dementia
• Alzheimer's Disease
• Cognitive Aging
• +7 more

Scientia Professor Henry Brodaty is a leading researcher in dementia and cognitive aging at the University of New South Wales, where he serves as Director of the Centre for Healthy Brain Ageing. His work spans clinical practice, research, and community engagement, with a focus on improving outcomes for older adults and their caregivers. He holds dual qualifications in medicine (MBBS) and psychiatry, with advanced degrees including MD and DSc from UNSW. Professor Brodaty's research interests center on dementia prevention, cognitive aging, and improving dementia care systems. His groundbreaking work includes the Maintain Your Brain study, which demonstrated the most successful online intervention to prevent cognitive decline in older adults, and the long-running Memory and Ageing Study that has followed thousands of participants over decades. His research has led to the development of the GPCOG screening tool now used in 22 languages worldwide, innovative approaches to managing behavioral symptoms in dementia, and evidence-based improvements in nursing home care. Analysis of his recent publications reveals a strong focus on multidomain interventions for cognitive decline prevention, neuroimaging biomarkers for dementia, the relationship between vascular health and cognition, and innovative care models for people living with dementia. His work consistently bridges basic science with practical applications that improve clinical care and quality of life for older adults. Professor Brodaty's scientific achievements have been recognized with numerous prestigious awards including the Ryman Prize (considered the 'Nobel Prize of Ageing'), the Alzheimer's Australia Lifetime Award, and Officer of the Order of Australia. His contributions to dementia research and care have had international impact, influencing clinical practice and policy worldwide. As an educator and mentor, Professor Brodaty currently supervises 4 PhD students as primary supervisor, 2 PhD students as mentor, 1 Master's student, and 1 Medical Honours student. His research has been supported by substantial grants including NHMRC Boosting Dementia Research Team Grants, NIH funding for international collaborations, and EU Joint Program for Neurodegenerative Diseases funding. Professor Brodaty leads the Centre for Healthy Brain Ageing, which brings together multidisciplinary teams to translate research into practice through initiatives like forwardwithdementia.org.au , which provides post-diagnostic support for people with dementia and their care partners. His work continues to shape dementia care policy and practice in Australia and internationally.

Perminder Singh SachdevView profile

Professor

• Neuropsychiatry
• Dementia
• Alzheimer's Disease
• +7 more

Scientia Professor Perminder Singh Sachdev AM, MBBS, MD, PhD, FRANZCP, FAAHMS serves as Professor of Neuropsychiatry at UNSW Sydney, Co-Director of the Centre for Healthy Brain Ageing (CHeBA), and Clinical Director of the Neuropsychiatric Institute at Prince of Wales Hospital in Sydney, Australia. His distinguished career spans multiple leadership roles including past-president of the International Neuropsychiatric Association and inaugural Chair of the Section of Neuropsychiatry of the Royal Australian and New Zealand College of Psychiatrists. Professor Sachdev completed his medical education at the All-India Institute of Medical Sciences, New Delhi (MBBS 1978), followed by an MD in Psychiatry (1983) at the same institution. He furthered his training in New Zealand and Australia, where he earned his PhD in 1991 with research focused on ethnopsychological concepts in Maori culture. His academic journey culminated in numerous professional qualifications including FRANZCP and FAAHMS. His research spans multiple critical areas in neuropsychiatry and aging, with particular emphasis on dementia and pre-dementia syndromes. His work integrates neuroimaging, neuropsychology, biomarkers, and risk factors to advance understanding of cognitive decline. Early in his career, he made significant contributions to understanding drug-induced movement disorders including akathisia, tardive dyskinesia, and neuroleptic malignant syndrome. More recently, his research has expanded to include brain stimulation techniques (TMS, DCS, VNS, and DBS) for psychiatric disorders. His work bridges clinical practice with population-based research through major longitudinal studies. Analysis of his recent publications reveals a strong focus on neuroimaging biomarkers for Alzheimer's disease, cognitive reserve mechanisms, genetic risk factors for dementia, and innovative interventions including transcranial magnetic stimulation. His work demonstrates consistent integration of clinical observations with rigorous scientific methodology across multiple disciplines including neuroscience, geriatrics, and neurogenetics. NSW Scientist of the Year for Biomedical Sciences (2010) Appointed Member of the Order of Australia (2011) Founder's Medal by the Australian Society for Psychiatric Research (2011) International Distinguished Fellow of the American Psychiatric Association (2012) UNSW Medicine Dean's award for outstanding contribution to research and teaching (2014) Fellow of the Australian Academy of Health and Medical Sciences (2015) Professor Sachdev has secured substantial funding to support his research programs, including leadership of three major longitudinal cognitive aging studies: Sydney Memory and Ageing Study, Older Australian Twins Study, and Sydney Centenarian Study. He also leads three international networks: COSMIC, STROKOG, and ICC-Dementia. His research has been supported by numerous grants from national and international funding bodies focused on brain health and dementia prevention. Beyond his formal academic roles, he serves as Chief Medical Adviser to Alzheimer's Australia and Medical Adviser to the Tourette Syndrome Association of Australia. The Centre for Healthy Brain Ageing (CHeBA), which Professor Sachdev co-founded in 2012, represents a major interdisciplinary research hub focused on promoting brain health and preventing dementia. CHeBA brings together researchers from diverse fields including neuroscience, psychology, genetics, and public health to address the complex challenges of cognitive aging. The institute maintains strong collaborations with clinical services at Prince of Wales Hospital through the Neuropsychiatric Institute, creating a seamless research-clinical interface.

• Neurology
• Pharmacology
• Mental Health
• +4 more

Jacques-Yves Montplaisir is a Full Professor in the Department of Psychiatry and Addictology at the University of Montreal's Faculty of Medicine. He serves as Director of the Center for Advanced Research in Sleep Medicine (CÉAMS) and holds the Canada Research Chair in Sleep Medicine. His work spans clinical, epidemiological, and neurophysiological research in sleep disorders. His educational background includes foundational work under Dr. Herbert Jasper at the Department of Physiology (1972) and research at Caltech with James Olds. He founded Canada's first sleep research center at Hôpital du Sacré-Coeur de Montréal in 1977 and has directed multiple research initiatives including the Fernand-Seguin Research Center. Neurological basis of sleep and circadian rhythms Pathophysiology and treatment of sleep disorders Biomarkers of Alzheimer's disease Longitudinal pediatric sleep studies Clinical pharmacology of sleep medications His research output shows consistent focus on REM sleep behavior disorder, sleepwalking, restless legs syndrome, and connections between sleep disorders and neurodegenerative conditions. Recent work increasingly examines sleep's role in cognitive impairment and dementia. Prix Léo-Pariseau (2004) Prix Wilder-Penfield (2007) Lifetime Contribution Award (World Sleep Federation, 2011) Ordre national du Québec (2017) Dr. Montplaisir has supervised over 20 graduate students across neuroscience, psychiatry, and sleep medicine disciplines. His research has been continuously funded for over 30 years by CIHR/IRSC, with major grants including a $5 million infrastructure grant from the Canadian Foundation for Innovation in 2006. He leads multiple large-scale research networks including the Canadian Sleep and Circadian Network. He directs the Center for Advanced Research in Sleep Medicine (CÉAMS) and collaborates extensively with the CIUSSS Nord-de-l'île-de-Montréal – Hôpital du Sacré-Cœur de Montréal. His work bridges clinical practice, research infrastructure development, and pharmaceutical industry collaboration.

Claire FlahertyView profile

Professor

• Cognitive Neuroscience
• Clinical Neuropsychology
• Frontotemporal Dementia
• +4 more

Claire Flaherty is a Professor in the Department of Neurology and Division of Neuropsychology at Penn State College of Medicine. She specializes in lifespan neuropsychology, with research focusing on cognitive dysfunction in neurodegenerative diseases and epilepsy. Board-certified clinical neuropsychologist (ABPN, 2013) Licensed in Pennsylvania since 1995 Her research spans: Gender differences in FTLD and ALS Neuroendocrine mechanisms of estrogen protection Frontal lobe pathology in criminal behavior Responsive neurostimulation for epilepsy Key publication trends include: 2015-2020 focus on FTLD biomarkers and interventions 2017 development of neuroendocrine models 2015 forensic analysis of female serial killers Clinical expertise covers: MCI/dementia progression prevention Subjective cognitive decline monitoring 504/IEP accommodations for developmental disorders

Mona GarvertView profile

Assistant Professor

• Cognitive Neuroscience
• Computational Neuroscience
• Decision Making
• +3 more

Mona Garvert is Junior Professor for Neuroscience at the Faculty of Human Sciences, University of Würzburg, Germany, since 2023. Previously, she served as Lead Research Scientist at Alena, London (2022-2023) and Group Leader at the Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig (2018-2021). Her research integrates cognitive neuroscience with computational modeling to investigate neural mechanisms of memory, decision-making, and learning. Education: PhD in Neuroscience (2011-2016), Wellcome Trust Centre for Neuroimaging, University College London MSc in Neuro-cognitive Psychology (2008-2010), Ludwig-Maximilians-Universität München Master 1 Biosciences (2007-2008), École Normale Superieure de Lyon Vordiplom Molekulare Medizin (2005-2007), Albert-Ludwigs-Universität Freiburg Research Focus: Dr. Garvert pioneers investigations into cognitive maps within the hippocampal-entorhinal system, extending beyond spatial navigation to abstract knowledge structures governing decision-making. Her work employs fMRI and computational modeling to reveal how grid-like neural representations encode value spaces during prospective choices, how spatio-predictive maps guide reward generalization, and how vmPFC mediates value signals. Recent clinical applications include developing digital psychotherapy for social anxiety. Key methodologies span reinforcement learning paradigms , relational memory tasks , and naturalistic decision-making experiments . Research Trends: Analysis of her 2022-2025 publications shows escalating focus on abstract cognitive mapping (extending hippocampal spatial codes to value domains), clinical translation (digital interventions for anxiety), and computational-social neuroscience (social influence on temporal discounting). Her work increasingly integrates multi-voxel pattern analysis with dynamic decision models, revealing how entorhinal grid codes support non-spatial generalization. Collaborations span Oxford, MPI Leipzig, and international computational neuroscience hubs. Research Team: Dr. Garvert leads a team at Würzburg including Yuheng Shi, Hannah Reichel, Ishita Goyal, and Johanna Heckmann. She serves as ad-hoc reviewer for Nature , Nature Communications , Neuron , and Wellcome Trust funding panels, reflecting her standing in computational cognitive neuroscience.

• Cognitive Neuroscience
• Autism Spectrum Disorder
• Brain Plasticity
• +7 more

Dr Melody Mei Yan Chan is a Research Fellow at the School of Health and Rehabilitation Sciences , University of Queensland. She is affiliated with the Queensland Brain Institute under the Faculty of Health, Medicine and Behavioural Sciences. Her research focuses on autism spectrum disorders (ASD), transcranial direct current stimulation (tDCS), neuroimaging, and cognitive neuroscience. Key research areas include: Neural mechanisms of creative thought in health and disease Theta-band oscillations and excitation-inhibition balance in ASD Neurophysiological effects of mind-body exercise Language production and semantic interference across age groups Modulation of brain connectivity through tDCS interventions Her recent publications highlight trends in tDCS applications for social and cognitive deficits in ASD, brain plasticity studies using EEG/fNIRS, and cross-domain meta-analyses of neural networks. She serves as an associate advisor for PhD projects on creative cognition and is available for supervision. Collaborations span institutions in Hong Kong and Australia.

• Pediatric Traumatic Brain Injury
• Autism Spectrum Disorders
• Functional Magnetic Resonance Imaging (fMRI)
• +14 more

Brandon A. Zielinski, MD, PhD, serves as the Director of Inpatient Neurology at Primary Children's Medical Center (PCMC) and holds adjunct faculty appointments in Pediatrics, Neurology, and Radiology & Imaging Sciences at the University of Utah. He joined the Division of Pediatric Neurology in 2010 following subspecialty training at the University of California San Francisco. His clinical expertise focuses on pediatric neurocritical care, stroke, traumatic brain injury (TBI), and advanced neuroimaging, establishing one of the few clinical fMRI services in the western U.S. Dr. Zielinski's research integrates basic and clinical neuroscience, with emphasis on: Autism Spectrum Disorders : Sex-dependent brain networks, longitudinal development, and sensory-motor integration Pediatric TBI : Neuroimaging biomarkers, outcome prediction, and cerebellar degeneration Advanced Neuroimaging : Clinical fMRI applications, structural covariance networks, and multi-modal MRI techniques His NIH and PCMC Foundation-funded work appears in high-impact journals including Proceedings of the National Academy of Sciences , Neuron , and Brain . Articles demonstrate consistent focus on neurodevelopmental disorders (75%) and TBI (20%), utilizing fMRI (60%), structural MRI (30%), and novel computational methods. Awards & Recognition: Child Neurology Society's Outstanding Junior Member Award for pioneering contributions to pediatric neuroimaging. Grants & Collaborations: Leads cross-departmental initiatives with Radiology and Psychiatry. Current funding includes NIH R01 grants for autism neuroimaging and PCMC Foundation awards for TBI biomarker discovery. Education: BS: Arizona State University PhD: Georgetown University Medical Center MD: University of Colorado Health Sciences Center Residency: University of Utah/Primary Children's Medical Center Fellowship/Chief Residency: University of California San Francisco